StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2022, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 02 Dec 2021 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Thu, 02 Dec 2021 07:00:00 -0400 A.06822034 AGN AGNPF AGW Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Thu, 02 Dec 2021 07:00:00 -0400 A.06822034 AGN AGNPF AGW Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Thu, 02 Dec 2021 07:00:00 -0400 A.06822034 AGN AGNPF AGW Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Thu, 02 Dec 2021 07:00:00 -0400 A.06822034 AGN AGNPF AGW Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Thu, 02 Dec 2021 07:00:00 -0400 A.06822034 AGN AGNPF AGW Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Thu, 02 Dec 2021 07:00:00 -0400 A.06822034 AGN AGNPF AGW Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Thu, 02 Dec 2021 07:00:00 -0400 A.06822034 AGN AGNPF AGW Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Projects+Full+Enrollment+for+Phase+2+IPF+and+Chronic+Cough+Trial/19299762.html Thu, 02 Dec 2021 07:00:00 -0400 A.06822034 AGN AGNPF AGW Algernon Pharmaceuticals Announces New Chief Financial Officer http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Tue, 30 Nov 2021 07:00:00 -0400 AGN AGNPF AGW MPH Algernon Pharmaceuticals Announces New Chief Financial Officer http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Tue, 30 Nov 2021 07:00:00 -0400 AGN AGNPF AGW MPH Algernon Pharmaceuticals Announces New Chief Financial Officer http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Tue, 30 Nov 2021 07:00:00 -0400 AGN AGNPF AGW MPH Algernon Pharmaceuticals Announces New Chief Financial Officer http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Tue, 30 Nov 2021 07:00:00 -0400 AGN AGNPF AGW MPH Algernon Pharmaceuticals Announces New Chief Financial Officer http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Tue, 30 Nov 2021 07:00:00 -0400 AGN AGNPF AGW MPH Algernon Pharmaceuticals Announces New Chief Financial Officer http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Tue, 30 Nov 2021 07:00:00 -0400 AGN AGNPF AGW MPH Algernon Pharmaceuticals Announces New Chief Financial Officer http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Tue, 30 Nov 2021 07:00:00 -0400 AGN AGNPF AGW MPH Algernon Pharmaceuticals Announces New Chief Financial Officer http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+New+Chief+Financial+Officer/19286053.html Tue, 30 Nov 2021 07:00:00 -0400 AGN AGNPF AGW MPH Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Wed, 24 Nov 2021 07:00:00 -0400 A.06822034 A.31896609 AGN AGNPF AGW Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Wed, 24 Nov 2021 07:00:00 -0400 A.06822034 A.31896609 AGN AGNPF AGW Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Wed, 24 Nov 2021 07:00:00 -0400 A.06822034 A.31896609 AGN AGNPF AGW Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Wed, 24 Nov 2021 07:00:00 -0400 A.06822034 A.31896609 AGN AGNPF AGW Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html for the full story. http://www.streetinsider.com/Press+Releases/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Wed, 24 Nov 2021 07:00:00 -0400 A.06822034 A.31896609 AGN AGNPF AGW Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Wed, 24 Nov 2021 07:00:00 -0400 A.06822034 A.31896609 AGN AGNPF AGW Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Wed, 24 Nov 2021 07:00:00 -0400 A.06822034 A.31896609 AGN AGNPF AGW Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Wed, 24 Nov 2021 07:00:00 -0400 A.06822034 A.31896609 AGN AGNPF AGW Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html for the full story. http://www.streetinsider.com/Globe+Newswire/Algernon+Pharmaceuticals+Announces+Positive+Feedback+from+U.S.+FDA+for+Phase+1+Ifenprodil+Small+Cell+Lung+Cancer+Study/19265593.html Wed, 24 Nov 2021 07:00:00 -0400 A.06822034 A.31896609 AGN AGNPF AGW